Janet Woodcock and National Institutes of Health

Selected healthcare news for the person - Janet Woodcock, and the healthcare topic - National Institutes of Health. We have 9 shared news items for this connection to-date.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
8/19/2021 Joint Statement from HHS Public Health and Medical Experts on COVID-19 Booster Shots ... Janet Woodcock, Acting Commissioner, Food and Drug Administration (FDA); Dr. Vivek Murthy, U.S. Surgeon General; Dr. Francis Collins, Director of the National Institutes of Health (NIH); Dr. Anthony Fauci, Chief Medical Advisor to President Joe Biden and Director of the National Institute of Allergy and Infectious Diseases (NIAID); Dr. Rachel Levine, Assistant Secretary for Health; Dr. David Kessler, Chief Science Officer for the COVID-19 Response; and Dr. Marcella Nunez ...
4/29/2021 FDA issues noncompliance notice for failing to submit clinical trial summary results to ClinicalTrials.gov ... B.Sc. Apr 28 2021 Statement from: Statement Author Leadership Role Acting Commissioner of Food and Drugs - Food and Drug Administration Janet Woodcock M.D.Being transparent about the results of completed clinical trials enables important advances ... results information to the ClinicalTrials.gov data bank, managed by the National Institutes of Health (NIH)/National Library of Medicine.Sponsors of clinical trials may represent a variety of organizations, including academic institutions, hospitals, private companies ...
4/28/2021 marylandlatinonews ... Trial Results Information to ClinicalTrials.GovSILVER SPRING, Md. , April 28, 2021 /PRNewswire/ -- The following is attributed to Acting FDA Commissioner Janet Woodcock , M.D.Being transparent about the results of completed clinical trials enables important advances ... results information to the ClinicalTrials.gov data bank, managed by the National Institutes of Health (NIH)/National Library of Medicine.Sponsors of clinical trials may represent a variety of organizations, including academic institutions, hospitals, private companies ...
4/28/2021 FDA Takes Action For Failure to Submit Required Clinical Trial Results Information to ClinicalTrials.Gov | FDA Janet Woodcock, M.D. Acting Commissioner of Food and Drugs - Food and Drug AdministrationBeing transparent about the results of completed clinical trials enables important advances in the development of medical products and helps ensure a ... results information to the ClinicalTrials.gov data bank, managed by the National Institutes of Health (NIH)/National Library of Medicine.Sponsors of clinical trials may represent a variety of organizations, including academic institutions, hospitals, private companies ...
7/23/2020 Opinion: Using a global network of adaptive clinical trials to fight Covid-19 STAT ... results: In April, data from an adaptive platform study called the Adaptive Covid-19 Treatment Trial, or ACTT, from the National Institutes of Health, validated the clinical benefits of remdesivir , an antiviral agent, in patients ... 19 struck. They’re a subset of master protocol trials that Janet Woodcock, the Food and Drug Administration’s long-serving director for drug evaluation and research, and Lisa LaVange explored in a review article in the ...
5/5/2020 Vaccine expert says he was punished for raising concerns about Trump’s coronavirus response, nepotism STAT ... and Development Authority, has filed a formal whistleblower complaint alleging he was involuntarily transferred to a lower position at the National Institutes of Health because he raised concerns about the Trump administration’s Covid-19 response ... Bright worked “frantically,” alongside top Food and Drug Administration official Janet Woodcock, to resist a plan to distribute the drug widely. Woodcock, according to the complaint, urged Bright directly to issue a so-called emergency ...
11/20/2019 12 burning questions for Stephen Hahn, Trump’s pick to lead FDA STAT ... fetal tissue, which is obtained from elective abortions. That included research being conducted by scientists at the FDA and the National Institutes of Health. HHS also said that any grant application for new or renewed ... for handling truly bespoke drugs. Last month, FDA center directors Janet Woodcock and Peter Marks wrote an editorial in the New England Journal of Medicine on personalized medicine. That editorial appeared alongside a report on ...
11/20/2019 12 burning questions for Stephen Hahn, Trump’s pick to lead FDA STAT ... fetal tissue, which is obtained from elective abortions. That included research being conducted by scientists at the FDA and the National Institutes of Health. HHS also said that any grant application for new or renewed ... for handling truly bespoke drugs. Last month, FDA center directors Janet Woodcock and Peter Marks wrote an editorial in the New England Journal of Medicine on personalized medicine. That editorial appeared alongside a report on ...
11/5/2019 FDA Keeps Brand-Name Drugs On A Fast Path To Market ― Despite Manufacturing Concerns Kaiser Health News ... Drug Administration gushed about what they’d accomplished. /p p “I voted ‘yes’ because, quite simply, this is a game changer,” National Institutes of Health hepatologist Dr. Marc Ghany said of Sovaldi, Gilead Science’s new pill ... they raise the possibility of “deeper issues.” /p p Dr. Janet Woodcock, the director of the FDA’s Center for Drug Evaluation and Research, said an inspector’s recommendation to withhold approval can be “dealt with” without ...